Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) to Webcast Business Update in Advance of 26th Annual JPMorgan Healthcare Conference

CAMBRIDGE, Mass., Dec. 27 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. will hold a live webcast of a conference call at 8:00 a.m. ET on Friday, January 4, 2008 in advance of the 26th Annual JPMorgan Healthcare Conference. Dr. Deborah Dunsire, president and chief executive officer of Millennium, will host the call. She will discuss the Company's key accomplishments in 2007 and goals and financial guidance for 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )

The live webcast can be accessed by visiting the Investors section of the Company's website, http://www.millennium.com. Following the webcast, an archived version of the call will be available at the same address for 30 days.

About Millennium

Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE(R) (bortezomib) for Injection, a novel cancer product, and has a robust clinical development pipeline of product candidates. The Company's research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium is developing an exciting pipeline of innovative product candidates. The Company's website is http://www.millennium.com.

Editors' Note: This press release is also available under the Media section of the Company's website at: http://www.millennium.com.

Contact:

Kyle Kuvalanka

(617) 761-4734

CONTACT: Kyle Kuvalanka of Millennium Pharmaceuticals, Inc.,
+1-617-761-4734

Web site: http://www.millennium.com/

Company News On-Call: http://www.prnewswire.com/comp/114562.html/